Emerald Health Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Emerald Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Emerald Health Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Emerald Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 26 M | |
| Total Cashflows From Investing Activities | 19.6 M | |
| Free Cash Flow | -18.1 M |
Emerald |
Emerald Health Relative Risk vs. Return Landscape
If you would invest (100.00) in Emerald Health Therapeutics on October 28, 2025 and sell it today you would earn a total of 100.00 from holding Emerald Health Therapeutics or generate -100.0% return on investment over 90 days. Emerald Health Therapeutics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Emerald, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Emerald Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emerald Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emerald Health Thera can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Emerald Health Thera is not yet fully synchronised with the market data | |
| Emerald Health Thera has some characteristics of a very speculative penny stock | |
| Emerald Health Thera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 9.68 M. Net Loss for the year was (39.41 M) with loss before overhead, payroll, taxes, and interest of (6.45 M). | |
| Emerald Health Therapeutics has accumulated about 15.52 M in cash with (17.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
Emerald Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Emerald OTC Stock often depends not only on the future outlook of the current and potential Emerald Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emerald Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 213.5 M | |
| Shares Float | 209.2 M |
Emerald Health Fundamentals Growth
Emerald OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Emerald Health, and Emerald Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Emerald OTC Stock performance.
| Return On Equity | -0.67 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (2.48) % | |||
| Current Valuation | (5.84 M) | |||
| Shares Outstanding | 213.47 M | |||
| Price To Earning | (20.19) X | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 9.68 M | |||
| EBITDA | (35.61 M) | |||
| Cash And Equivalents | 15.52 M | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.13 X | |||
| Cash Flow From Operations | (17.11 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 40.89 M | |||
Things to note about Emerald Health Thera performance evaluation
Checking the ongoing alerts about Emerald Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Emerald Health Thera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Emerald Health Thera is not yet fully synchronised with the market data | |
| Emerald Health Thera has some characteristics of a very speculative penny stock | |
| Emerald Health Thera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 9.68 M. Net Loss for the year was (39.41 M) with loss before overhead, payroll, taxes, and interest of (6.45 M). | |
| Emerald Health Therapeutics has accumulated about 15.52 M in cash with (17.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
- Analyzing Emerald Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Emerald Health's stock is overvalued or undervalued compared to its peers.
- Examining Emerald Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Emerald Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Emerald Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Emerald Health's otc stock. These opinions can provide insight into Emerald Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Health Thera check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Health's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |